Purinergic Receptor Transactivation by the β2-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells
Purinergic Receptor Transactivation by the β2-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells
复制标题
DOI:
10.1124/mol.116.106419
复制
发表时间:
2017-05-01
影响因子:
3.6
通讯作者:
Bouvier, Michel
中科院分区:
文献类型:
--
作者:
Stallaert, Wayne;van der Westhuizen, Emma T.;Bouvier, Michel
The beta(2) adrenergic receptor (beta(2)AR) increases intracellular Ca2+ in a variety of cell types. By combining pharmacological and genetic manipulations, we reveal a novel mechanism through which the beta(2)AR promotes Ca2+$ mobilization (pEC(50) = 7.32 +/- 0.10) in nonexcitable human embryonic kidney (HEK) 293S cells. Downregulation of Gs with sustained cholera toxin pretreatment and the use of Gs-null HEK293 (Delta Gs-HEK293) cells generated using the clustered regularly interspaced short palindromic repeat-associated protein-9 nuclease (CRISPR/Cas9) system, combined with pharmacological modulation of cAMP formation, revealed a Gs-dependent but cAMP-independent increase in intracellular Ca2+ following beta(2)AR stimulation. The increase in cytoplasmic Ca2+ was inhibited by P2Y purinergic receptor antagonists as well as a dominant-negative mutant form of Gq, a Gq-selective inhibitor, and an inositol 1,4,5-trisphosphate (IP3) receptor antagonist, suggesting a role for this Gq-coupled receptor family downstream of the beta(2)AR activation. Consistent with this mechanism, beta(2)AR stimulation promoted the extracellular release of ATP, and pretreatment with apyrase inhibited the beta(2) AR-promoted Ca2+ mobilization. Together, these data support a model whereby the beta(2)AR stimulates a Gs-dependent release of ATP, which transactivates Gq-coupled P2Y receptors through an inside-out mechanism, leading to a Gq-and IP3 dependent Ca2+ mobilization from intracellular stores. Given that beta(2)AR and P2Y receptors are coexpressed in various tissues, this novel signaling paradigm could be physiologically important and have therapeutic implications. In addition, this study reports the generation and validation of HEK293 cells deleted of Gs using the CRISPR/Cas9 genome editing technology that will undoubtedly be powerful tools to study Gs-dependent signaling.